Canada
Europe CIS
Germany
Mauritius
Netherlands
Notre Dame de Bondeville
Latin America
Australia
China
Japan
Malaysia
Philippines
Taiwan
Nutritionals
Beta Healthcare
Kama
Nigeria
Shelys
Sustainability Overview
Our vision, “to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally", encapsulates the Group’s inherent approach of conducting business ethically, with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.
OUR APPROACH TO SUSTAINABILITY
We recognise that doing business in a sustainable manner is integral to ensuring our future viability. As such sustainability considerations underpin our strategy and are integrated into our day-to-day-activities.
Our material sustainability issues are grouped into 10 sustainability objectives which are aligned to the Group’s strategic objectives, the related capitals and the relevant key performance indicators ("KPIs"). The Audit & Risk Committee reviews and approves the sustainability objectives and the related KPIs. The Board monitors the sustainability performance with reference to these KPIs on a regular basis.
Material sustainability issues are determined through ongoing interactions with our key stakeholders with reference to:
• external factors impacting the Group’s business model and pursuit of strategic objectives;
• key business risks impacting the Group’s sustainability;
• the value exchange and/or opportunity cost of the applied intellectual, manufactured, human, social & relationship, natural and financial capitals to the business as well as the responsible management of these; and
• our responsibility to stakeholders and transparency in reporting with reference to the GRI Sustainability Reporting Standards, King IV, Companies Act of South Africa, BBBEE Codes in South Africa, the JSE/FTSE Responsible Investment Index, the Carbon Disclosure Project and the UN Global Compact.
ASSURANCE
Assurance in respect of the sustainability KPIs is obtained by means of a combined assurance approach, with ERM providing assurance on the key environmental, health and safety indicators in line with the AccountAbility AA1000 Assurance Standard, PwC providing assurance on the financial indicators and other assurance providers such as the Group’s Internal Audit and Empowerdex providing assurance on the balance of the indicators reported.
Contact Details
Downloads
Aspen 2017 Sustainability Data Supplement
• PDF 1MB
Equity Report - Fine Chemicals Workforce Profile 2016
• PDF 176KB
Equity Report - Pharmacare Workforce Profile 2016
•PDF 175.8KB
Aspen 2017 PWC KPI Assurance Report
• PDF 1MB
Aspen 2017 ERM Assurance Statement
•PDF 166.8KB
Aspen CDP 2017
•PDF 896KB
Aspen CPD Water 2017
•PDF 632KB
Aspen Environmental Management Principles
•PDF 71KB
Aspen Australia - Dandenong ISO 14001
•PDF 402KB
Aspen Australia - Dandenong OHSAS 18001
•PDF 402KB
Aspen Pharma - ISO 14001
•PDF 314KB
Aspen Pharma - OHSAS 18001
• PDF 299KB
Aspen NDB - ISO 14001
•PDF 504KB
Aspen NDB - OHSAS 18001
• PDF 509KB
Aspen Bad Oldesloe ISO 14001 and ISO 9001
• PDF 1MB
Aspen Bad Oldesloe ISO 50001
•PDF 1MB
Aspen Bad Oldesloe - OHSAS 18001
• PDF 1MB
Aspen South African Operations ISO 14001
• PDF 808KB
Aspen South African Operations OHSAS 18001
•PDF 791KB
Aspen Bad Oldesloe - OHSAS 18001
• PDF 1MB
Aspen Labs - Vallejo ISO 14001
•PDF 138KB
Aspen Labs - Vallejo OHSAS 18001
•PDF 126KB
Intellectual
Capital
Manufactured
Capital
Human
Capital
Social & Relationship Capital
Natural
Capital
Financial
Capital
Intellectual Capital
Our intellectual capital supports our focused therapeutic basket of high quality, affordable medicines and products.
Strategic objective
To enhance access to high quality, affordable medicines
Aspen's sustainability objectives
Sustaining life and health through high quality, affordable medicines
Material KPIs
- IMS Health (Pty) Limited value of total product pipeline for the next five years
- Number of product recalls
Assurance provider: Internal Audit
Manufactured Capital
The investment in our API facilities and FDF manufacturing capabilities aimed at delivering integrated and operational synergies is a key enabler in supporting our mission to produce high quality, affordable medicines and products, enhancing access to healthcare in over 150 countries.
Strategic objective
To achieve strategic advantage through our integrated supply chain
Aspen's sustainability objectives
Sustaining a cost-competitive manufacturing base
Material KPIs
- Return on total assets
- EBITDA margin
Assurance provider: PwC
Human Capital
Built on the foundation of our values and a commitment to the Group Code of Conduct, we strive to provide a safe, challenging and rewarding environment for each of our employees.
Strategic objective
To provide a safe, challenging and rewarding environment for our employees
Aspen's sustainability objectives
Creating an environment in which our employees can thrive
Providing a safe working environment
Material KPIs
- Average staff turnover
- Average training spend per employee
Assurance provider: Internal Audit
- Disabling incident frequency rate
- Lost work day frequency rate
Assurance provider: ERM
Social & relationship Capital
Responsible corporate citizenship is more than a compliance requirement, it is fundamental to our objectives and the way we do business. We recognise that there are inseparable linkages between our sustainable growth, our relationships with our stakeholders and its contribution to society in the broader context.
Strategic objective
To practise good corporate citizenship
Aspen's sustainability objectives
Promoting equality
Conducting our business in a responsible manner
Material KPIs
- Percentage of female employees
- Percentage of black employees in South Africa
Assurance provider: Internal Audit
- BBBEE accreditation in South Africa
Assurance provider: Empowerdex
- Number of material incidents of legislative infringements
Assurance provider: Internal Group Compliance officer review
Natural Capital
As a manufacturer of quality medicines, APIs and nutritional products, we are reliant on the conversion and use of natural capital in creating value for its stakeholders. We recognize that our operations directly and indirectly impact the environment and the Aspen Environmental Management Protocol affirms our commitment reducing our impact on the environment, responsible environmental management, conservation and protection across all of our operations.
Strategic objective
To practise good corporate citizenship
Aspen's sustainability objectives
Preserving the environment
Managing the efficient utilisation of scarce resources
Material KPIs
- Carbon emissions
- Waste recycled
Assurance provider: ERM
- Water used
- Electricity used
Financial Capital
We aim to create value for all of our stakeholders, by managing our financial capital in a commercially astute and diligent manner thereby harnessing opportunities for long-term sustainable economic growth.
Strategic objective
To create sustainable economic value for all of our stakeholders
Aspen's sustainability objectives
Adding economic value to stakeholders
Maintenance of financial health
Material KPIs
- Growth in revenue
- Growth in normalised headline earnings per share
- Growth in EBITDA
- Return on ordinary shareholders’ equity
- Value added per permanent employee
Assurance provider: PwC
- Operating cash flow per share
- Leveraging ratio